HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.

Abstract
The objective of this study was to examine HLA-DRB1 and HLA-DQB1 genotypes in patients with severe extra-articular rheumatoid arthritis (ExRA) and to compare them with the genotypes of rheumatoid arthritis (RA) patients without extra-articular manifestations. Patients with severe ExRA were recruited from a large research database of patients with RA, from two cohorts of prevalent RA cases, and from a regional multicenter early RA cohort. Cases with ExRA manifestations (n = 159) were classified according to predefined criteria. Controls (n = 178) with RA but no ExRA were selected from the same sources. Cases and controls were matched for duration of RA and for clinical center. PCR based HLA-DRB1 and HLA-DQB1 genotyping was performed using the Biotest SSP kit, with additional sequencing in order to distinguish DRB1*04 subtypes. Associations between alleles and disease phenotypes were tested using multiple simulations of random distributions of alleles. There was no difference in global distribution of HLA-DRB1 and HLA-DQB1 alleles between patients with ExRA and controls. DRB1*0401 (P = 0.003) and 0401/0401 homozygosity (P = 0.002) were more frequent in Felty's syndrome than in controls. The presence of two HLA-DRB1*04 alleles encoding the shared epitope (SE) was associated with ExRA (overall odds ratio 1.79, 95% confidence interval 1.04-3.08) and with rheumatoid vasculitis (odds ratio 2.44, 95% confidence interval 1.22-4.89). In this large sample of patients with ExRA, Felty's syndrome was the only manifestation that was clearly associated with HLA-DRB1*0401. Other ExRA manifestations were not associated with individual alleles but with DRB1*04 SE double dose genotypes. This confirms that SE genes contribute to RA disease severity and ExRA. Other genetic and environmental factors may have a more specific impact on individual ExRA manifestations.
AuthorsCarl Turesson, Daniel J Schaid, Cornelia M Weyand, Lennart T H Jacobsson, Jörg J Goronzy, Ingemar F Petersson, Gunnar Sturfelt, Britt-Marie Nyhäll-Wåhlin, Lennart Truedsson, Sonja A Dechant, Eric L Matteson
JournalArthritis research & therapy (Arthritis Res Ther) Vol. 7 Issue 6 Pg. R1386-93 ( 2005) ISSN: 1478-6362 [Electronic] England
PMID16277691 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes
  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • HLA-DRB1*04:01 antigen
Topics
  • Arthritis, Rheumatoid (complications, genetics, pathology)
  • Disease Susceptibility
  • Epitopes (genetics)
  • Felty Syndrome (complications, genetics, pathology)
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HLA-DQ Antigens (genetics)
  • HLA-DQ beta-Chains
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Histocompatibility Testing
  • Humans
  • Linkage Disequilibrium
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: